Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain
Open Access
- 15 March 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-13
Abstract
The immunogenicity of mRNA vaccines has not been well studied when compared to different vaccine modalities in the context of additional boosters. Here we show that longitudinal analysis reveals more sustained SARS-CoV-2 spike receptor-binding domain (RBD)-binding IgG titers with the breadth to antigenically distinct variants by the S-268019-b spike protein booster compared to the BNT162b2 mRNA homologous booster. The durability and breadth of RBD-angiotensin-converting enzyme 2 (ACE2) binding inhibitory antibodies are pronounced in the group without systemic adverse events (AEs) after the S-268019-b booster, leading to the elevated neutralizing activities against Omicron BA.1 and BA.5 variants in the stratified group. In contrast, BNT162b2 homologous booster elicited antibodies to spike N-terminal domain in proportion to the AE scores. High-dimensional immune profiling identifies early CD16+ natural killer cell dynamics with CCR3 upregulation, as one of the correlates for the distinct anti-RBD antibody responses by the S-268019-b booster. Our results illustrate the combinational effects of heterologous booster on the immune dynamics and the durability and breadth of recalled anti-RBD antibody responses against emerging virus variants.Keywords
Funding Information
- MEXT | Japan Society for the Promotion of Science (JP21K16128)
- Japan Agency for Medical Research and Development (JP20fk0108534, JP22mk0101224, JP22fk0108141, JP22mk0101224)
This publication has 71 references indexed in Scilit:
- Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular SignaturesImmunity, 2015
- Boosting vaccine efficacy the natural (killer) wayTrends in Immunology, 2015
- Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trialVaccine, 2013
- Involvement of Ceramide in the Propagation of Japanese Encephalitis VirusJournal of Virology, 2010
- Systems biology approach predicts immunogenicity of the yellow fever vaccine in humansNature Immunology, 2008
- Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 primingNature Immunology, 2004
- IL-16 Promotes Leukotriene C4 and IL-4 Release from Human Eosinophils via CD4- and Autocrine CCR3-Chemokine-Mediated SignalingThe Journal of Immunology, 2002
- Extranuclear Lipid Bodies, Elicited by CCR3-mediated Signaling Pathways, Are the Sites of Chemokine-enhanced Leukotriene C4 Production in Eosinophils and BasophilsJournal of Biological Chemistry, 2001
- Production of IL-10 by Human Natural Killer Cells Stimulated with IL-2 and/or IL-12The Journal of Immunology, 1998
- The Role of Antibody Feedback Inhibition in the Regulation of the Secondary Antibody Response after High and Low Dose PrimingThe Journal of Immunology, 1975